Riik: Lõuna-Aafrika Vabariik
keel: inglise
Allikas: South African Health Products Regulatory Authority (SAHPRA)
Adcock Ingram Limited
See ingredients
CAPSULES
EACH CAPSULE CONTAINS OMEPRAZOLE 10,0 mg
Registered
2008-09-12
ADCOCK INGRAM LIMITED RAPACID, capsules Contains 10 mg omeprazole per capsule_ _ PROPOSED PATIENT INFORMATION LEAFLET Date of submission: 15 January 2021 1.3.2 Rapacid clean proposed PIL Page 1 of 7 1.3.2 CLEAN PROPOSED PATIENT INFORMATION LEAFLET SCHEDULING STATUS S2 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RAPACID capsule READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING RAPACID: • Keep this leaflet. You may need to read it again. • If you have further questions, please ask your doctor or your pharmacist. • RAPACID has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours. 1. WHAT RAPACID CONTAINS The active substance is omeprazole. RAPACID contains 10 mg omeprazole. The other ingredients are disodium phosphate anhydrous, gelatine, hypromellose, macrogol 6000, maize starch, mannitol, methacrylic acid-ethyl acrylate copolymer, polysorbate 80, quinoline yellow, sodium lauryl sulphate, sucrose, talc, titanium dioxide. Contains sugar (54,5 mg sucrose) and sugar alcohol (3,955 mg mannitol). 2. WHAT RAPACID IS USED FOR RAPACID is indicated for the temporary, short-term relief of heartburn and hyperacidity (excessive acid). 3. BEFORE YOU TAKE RAPACID DO NOT TAKE RAPACID: • If you are hypersensitive (allergic) to omeprazole or any of the other ingredients of RAPACID (see WHAT RAPACID CONTAINS). ADCOCK INGRAM LIMITED RAPACID, capsules Contains 10 mg omeprazole per capsule_ _ PROPOSED PATIENT INFORMATION LEAFLET Date of submission: 15 January 2021 1.3.2 Rapacid clean proposed PIL Page 2 of 7 • If you are pregnant or breastfeeding; safety has not been established. TAKE SPECIAL CARE WITH RAPACID: • RAPACID may hide symptoms of other diseases. If you experience any of the following symptoms while taking RAPACID contact your doctor immediately: Stomach pain or indigestion. Losing weight for no reason. Difficulty in swallowing. Vomiting (being sick) of blood. Black stools (bl Lugege kogu dokumenti
ADCOCK INGRAM LIMITED RAPACID, capsules Contains 10 mg omeprazole per capsule_ _ PROPOSED PROFESSIONAL INFORMATION Date of submission: 15 January 2021 1.3.1.1 Rapacid clean proposed PI Page 1 of 8 1.3.1.1 CLEAN PROPOSED PROFESSIONAL INFORMATION SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM RAPACID capsule COMPOSITION Each capsule contains 10 mg omeprazole. EXCIPIENTS: Disodium phosphate anhydrous, gelatine, hypromellose, macrogol 6000, maize starch, mannitol, methacrylic acid-ethyl acrylate copolymer, polysorbate 80, quinoline yellow, sodium lauryl sulphate, sucrose, talc, titanium dioxide. Contains sugar (54,5 mg sucrose) and sugar alcohol (3,955 mg mannitol). PHARMACOLOGICAL CLASSIFICATION A 11.4.3 Medicines acting on the gastrointestinal tract – other PHARMACOLOGICAL ACTION PHARMACODYNAMIC PROPERTIES Omeprazole is an inhibitor of the gastric proton pump (H+,K+-ATPase). It inhibits both basal and stimulated gastric acid secretion by parietal cells, whether induced by acetylcholine, gastrin or histamine. Omeprazole has no effect on acetylcholine, histamine or gastrin receptors. PHARMACOKINETIC PROPERTIES Orally administered omeprazole is well absorbed but to a variable extent. Absorption of omeprazole takes place in the small intestine and is usually completed within three to six hours. Bioavailability depends on the dose and gastric pH, and may reach 70 % with repeated administration. Food has no influence on the bioavailability of omeprazole. Omeprazole is more than 95 % bound to plasma proteins. Clearance from the circulation is by hepatic metabolism with a plasma half-life of 30 to 90 minutes. ADCOCK INGRAM LIMITED RAPACID, capsules Contains 10 mg omeprazole per capsule_ _ PROPOSED PROFESSIONAL INFORMATION Date of submission: 15 January 2021 1.3.1.1 Rapacid clean proposed PI Page 2 of 8 Hepatic metabolism occurs primarily via the cytochrome P450 (CYP) isoform (CYP2C19). The inactive metabolites are excreted mainly in the urine (80 %) whilst the remaining 20 % are excreted via the faeces. The avera Lugege kogu dokumenti